Rituximab administration in a community hospital environment.
Nimish
N
Shah
Simon
S
Rule
D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage* / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006764:Hospitals, Community; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab